8 Knots Management LLC Makes New $28.52 Million Investment in Cardinal Health, Inc. $CAH

8 Knots Management LLC bought a new position in Cardinal Health, Inc. (NYSE:CAH - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 138,795 shares of the company's stock, valued at approximately $28,522,000. Cardinal Health comprises approximately 3.3% of 8 Knots Management LLC's holdings, making the stock its 9th largest holding. 8 Knots Management LLC owned approximately 0.06% of Cardinal Health as of its most recent SEC filing.

Other large investors have also bought and sold shares of the company. Redhawk Wealth Advisors Inc. raised its holdings in shares of Cardinal Health by 0.5% during the fourth quarter. Redhawk Wealth Advisors Inc. now owns 9,255 shares of the company's stock valued at $1,902,000 after purchasing an additional 48 shares during the last quarter. HF Advisory Group LLC raised its holdings in shares of Cardinal Health by 0.9% during the fourth quarter. HF Advisory Group LLC now owns 5,227 shares of the company's stock valued at $1,074,000 after purchasing an additional 49 shares during the last quarter. Hillsdale Investment Management Inc. raised its holdings in shares of Cardinal Health by 0.9% during the fourth quarter. Hillsdale Investment Management Inc. now owns 5,760 shares of the company's stock valued at $1,184,000 after purchasing an additional 50 shares during the last quarter. Generali Asset Management SPA SGR raised its holdings in shares of Cardinal Health by 11.0% during the fourth quarter. Generali Asset Management SPA SGR now owns 513 shares of the company's stock valued at $105,000 after purchasing an additional 51 shares during the last quarter. Finally, Stephens Inc. AR raised its holdings in shares of Cardinal Health by 0.9% during the fourth quarter. Stephens Inc. AR now owns 5,951 shares of the company's stock valued at $1,223,000 after purchasing an additional 52 shares during the last quarter. 87.17% of the stock is owned by hedge funds and other institutional investors.

Cardinal Health Trading Up 1.2%

Shares of NYSE CAH opened at $223.76 on Friday. The firm has a 50 day moving average of $203.21 and a 200 day moving average of $208.85. The firm has a market capitalization of $52.41 billion, a price-to-earnings ratio of 34.21, a price-to-earnings-growth ratio of 1.22 and a beta of 0.52. Cardinal Health, Inc. has a 12-month low of $137.75 and a 12-month high of $233.60.

Cardinal Health (NYSE:CAH - Get Free Report) last announced its earnings results on Thursday, April 30th. The company reported $3.17 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.79 by $0.38. The company had revenue of $60.94 billion during the quarter, compared to analyst estimates of $62.10 billion. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. The firm's quarterly revenue was up 11.0% compared to the same quarter last year. During the same period in the previous year, the business posted $2.35 earnings per share. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. Sell-side analysts predict that Cardinal Health, Inc. will post 10.76 EPS for the current year.

Cardinal Health Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Investors of record on Wednesday, July 1st will be given a dividend of $0.5158 per share. This represents a $2.06 annualized dividend and a yield of 0.9%. This is a positive change from Cardinal Health's previous quarterly dividend of $0.51. The ex-dividend date is Wednesday, July 1st. Cardinal Health's dividend payout ratio (DPR) is presently 31.19%.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on CAH shares. JPMorgan Chase & Co. decreased their price objective on shares of Cardinal Health from $243.00 to $215.00 and set a "neutral" rating for the company in a report on Monday, May 4th. William Blair started coverage on shares of Cardinal Health in a report on Tuesday, April 28th. They set an "outperform" rating for the company. Leerink Partners reissued an "outperform" rating and set a $275.00 price objective on shares of Cardinal Health in a report on Monday, March 9th. TD Cowen boosted their price objective on shares of Cardinal Health from $251.00 to $255.00 and gave the company a "buy" rating in a report on Friday, May 1st. Finally, Evercore decreased their price objective on shares of Cardinal Health from $260.00 to $240.00 and set an "outperform" rating for the company in a report on Wednesday, April 8th. One investment analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat.com, Cardinal Health presently has a consensus rating of "Moderate Buy" and a consensus target price of $246.93.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company's core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.